Olaris is pleased to announce the publication of clinical data in iScience demonstrating the utility of its non-invasive myOLARIS®-KTdx urine test in kidney transplant patients. The study shows that ...

Treace Medical Concepts, Inc. ('Treace” or the 'Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...

Key opportunities in the cognitive assessment and training market include addressing the needs of the growing geriatric ...

An international team led by the Clínic-IDIBAPS-UB along with the Institute of Cancer Research, London, has developed a new ...

The clinical trial logistics market will hit $9.04 billion by 2030, fuelled by cold chain growth and decentralised trial ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...

Stroke continues to be a leading cause of mortality and long-term disability worldwide, presenting significant challenges in prevention, acute intervention, ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced its collaboration with ...

As personalised medicine continues to evolve, emerging technologies like spatialomics and AI are paving the way for ...

Smith+Nephew (NYSE: SNN) today announced new evidence highlighting the clinical performance of its Regeneten bioinductive implant.

Against the backdrop of the rapid development of pig farming in China, traditional farming management models are gradually revealing a series of problems, such as information asymmetry, delayed ...

ESCCA As a leading forum for scientific exchange in flow cytometry, ESCCA focuses on clinical applications in hematology, immunology, cancer, and cell biology. ESCCA 2025 will be held in Montpellier, ...